Campbell Newman Asset Management Inc
Source: SEC Form 13F · as of Mar 2026Campbell Newman Asset Management Inc holds 12 biotech & pharma companies tracked by BioSniper, totaling $82.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$82.4M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 165,389 | $36.0M |
| LLYELI LILLY & Co | 31,129 | $28.6M |
| MEDPMedpace Holdings Inc. | 9,188 | $4.4M |
| LNTHLantheus Holdings, Inc. | 35,206 | $2.7M |
| HALOHALOZYME THERAPEUTICS, INC. | 36,130 | $2.3M |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 44,808 | $2.3M |
| CPRXCATALYST PHARMACEUTICALS, INC. | 92,476 | $2.3M |
| ALHCAlignment Healthcare Inc. | 104,627 | $1.8M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,622 | $724K |
| CORTCORCEPT THERAPEUTICS INC | 17,251 | $695K |
| ABTABBOTT LABORATORIES | 2,481 | $255K |
| JNJJOHNSON & JOHNSON | 955 | $233K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.